TNF and rheumatoid arthritis: In the same way, a study carried out by our group in 113 RA subjects showed that TNF-α gene promoter polymorphisms, G-308A and G-238A, and the SE and DR3 alleles do not correlate with the response to Infliximab after 30 weeks quantified by improvement of DAS 28 [103].